CRA is a proud sponsor of this event.
Ashley Fraser is moderating a panel that will discuss how to “Prepare your Organization for Changes to Canada’s Drug Procurement Strategy.”
For more information on this event, click here.
Rare disease PMA trends in France: Price achieved vs. disease prevalence
In this installment, we examine the relationship between launch prices in France and disease prevalence as reported in the Haute Autorité de Santé assessments.